Abstract
Cathepsin K is a cysteine protease of the papain family, which is predominantly expressed in osteoclasts, and is regarded as a key protease in bone remodeling. To facilitate structural studies of the protein, the wild-type sequence of the protease has been mutated so as to replace a potential N-glycosylation site. We have expressed the mutant human cathepsin K to 190 mg/5 L using the Pichia pastoris expression system. Cathepsin K was inactivated with the mechanism-based inhibitor, APC3328, and crystallized from magnesium formate. A 2.2 A X-ray data set has been collected on crystals belonging to space group P2(1)2(1)2(1), with a = 41.66 A, b = 51.41 A, and c = 107.72 A. There is most likely one molecule per asymmetric unit.
Full Text
The Full Text of this article is available as a PDF (318.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bossard M. J., Tomaszek T. A., Thompson S. K., Amegadzie B. Y., Hanning C. R., Jones C., Kurdyla J. T., McNulty D. E., Drake F. H., Gowen M. Proteolytic activity of human osteoclast cathepsin K. Expression, purification, activation, and substrate identification. J Biol Chem. 1996 May 24;271(21):12517–12524. doi: 10.1074/jbc.271.21.12517. [DOI] [PubMed] [Google Scholar]
- Brömme D., Klaus J. L., Okamoto K., Rasnick D., Palmer J. T. Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem J. 1996 Apr 1;315(Pt 1):85–89. doi: 10.1042/bj3150085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brömme D., Okamoto K. Human cathepsin O2, a novel cysteine protease highly expressed in osteoclastomas and ovary molecular cloning, sequencing and tissue distribution. Biol Chem Hoppe Seyler. 1995 Jun;376(6):379–384. doi: 10.1515/bchm3.1995.376.6.379. [DOI] [PubMed] [Google Scholar]
- Brömme D., Okamoto K., Wang B. B., Biroc S. Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme. J Biol Chem. 1996 Jan 26;271(4):2126–2132. doi: 10.1074/jbc.271.4.2126. [DOI] [PubMed] [Google Scholar]
- Coulombe R., Grochulski P., Sivaraman J., Ménard R., Mort J. S., Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 1996 Oct 15;15(20):5492–5503. [PMC free article] [PubMed] [Google Scholar]
- Drake F. H., Dodds R. A., James I. E., Connor J. R., Debouck C., Richardson S., Lee-Rykaczewski E., Coleman L., Rieman D., Barthlow R. Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts. J Biol Chem. 1996 May 24;271(21):12511–12516. doi: 10.1074/jbc.271.21.12511. [DOI] [PubMed] [Google Scholar]
- Everts V., Beertsen W., Schröder R. Effects of the proteinase inhibitors leupeptin and E-64 on osteoclastic bone resorption. Calcif Tissue Int. 1988 Sep;43(3):172–178. doi: 10.1007/BF02571316. [DOI] [PubMed] [Google Scholar]
- Gelb B. D., Edelson J. G., Desnick R. J. Linkage of pycnodysostosis to chromosome 1q21 by homozygosity mapping. Nat Genet. 1995 Jun;10(2):235–237. doi: 10.1038/ng0695-235. [DOI] [PubMed] [Google Scholar]
- Gelb B. D., Shi G. P., Chapman H. A., Desnick R. J. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science. 1996 Aug 30;273(5279):1236–1238. doi: 10.1126/science.273.5279.1236. [DOI] [PubMed] [Google Scholar]
- Hill P. A., Buttle D. J., Jones S. J., Boyde A., Murata M., Reynolds J. J., Meikle M. C. Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem. 1994 Sep;56(1):118–130. doi: 10.1002/jcb.240560116. [DOI] [PubMed] [Google Scholar]
- Inaoka T., Bilbe G., Ishibashi O., Tezuka K., Kumegawa M., Kokubo T. Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone. Biochem Biophys Res Commun. 1995 Jan 5;206(1):89–96. doi: 10.1006/bbrc.1995.1013. [DOI] [PubMed] [Google Scholar]
- Kunkel T. A., Roberts J. D., Zakour R. A. Rapid and efficient site-specific mutagenesis without phenotypic selection. Methods Enzymol. 1987;154:367–382. doi: 10.1016/0076-6879(87)54085-x. [DOI] [PubMed] [Google Scholar]
- Li Y. P., Alexander M., Wucherpfennig A. L., Yelick P., Chen W., Stashenko P. Cloning and complete coding sequence of a novel human cathepsin expressed in giant cells of osteoclastomas. J Bone Miner Res. 1995 Aug;10(8):1197–1202. doi: 10.1002/jbmr.5650100809. [DOI] [PubMed] [Google Scholar]
- Liao J. C., Lenney J. F. Cathepsins J and K: high molecular weight cysteine proteinases from human tissues. Biochem Biophys Res Commun. 1984 Nov 14;124(3):909–916. doi: 10.1016/0006-291x(84)91044-1. [DOI] [PubMed] [Google Scholar]
- Matthews B. W. Solvent content of protein crystals. J Mol Biol. 1968 Apr 28;33(2):491–497. doi: 10.1016/0022-2836(68)90205-2. [DOI] [PubMed] [Google Scholar]
- McGrath M. E., Eakin A. E., Engel J. C., McKerrow J. H., Craik C. S., Fletterick R. J. The crystal structure of cruzain: a therapeutic target for Chagas' disease. J Mol Biol. 1995 Mar 24;247(2):251–259. doi: 10.1006/jmbi.1994.0137. [DOI] [PubMed] [Google Scholar]
- Palmer J. T., Rasnick D., Klaus J. L., Brömme D. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem. 1995 Aug 18;38(17):3193–3196. doi: 10.1021/jm00017a002. [DOI] [PubMed] [Google Scholar]
- Shi G. P., Chapman H. A., Bhairi S. M., DeLeeuw C., Reddy V. Y., Weiss S. J. Molecular cloning of human cathepsin O, a novel endoproteinase and homologue of rabbit OC2. FEBS Lett. 1995 Jan 3;357(2):129–134. doi: 10.1016/0014-5793(94)01349-6. [DOI] [PubMed] [Google Scholar]
